Retinol Palmitate

维生素A棕榈酸酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRetinol Palmitate
Drug Alias NameVitamin A palmitateall-trans-Retinyl esterChocola AAquasol AArovit +[6] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionRetinoid X receptor agonistsRetinoic acid receptors agonists
TargetsRetinoid X receptorRetinoic acid receptors
Therapy Area/IndicationsNight BlindnessXerophthalmia
Global Approved IndicationsNight BlindnessXerophthalmia
Approved Indications in ChinaNight BlindnessXerophthalmia
Original Approved Country/TerritoryUnited States
Original Approved Date1949/05/18
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCasper Pharma Llc
Inactive CompaniesN/A
Active IndicationsNight BlindnessXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeD10AD02R01AX02S01XA02
Related LinksWikipediaKEGG